Meng Lingzhan, Liu Zhenwen, Zhu Zhenyu. Research progress on risk factors of de novo malignancy after liver transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(5): 646-650. DOI: 10.3969/j.issn.1674-7445.2020.05.019
Citation: Meng Lingzhan, Liu Zhenwen, Zhu Zhenyu. Research progress on risk factors of de novo malignancy after liver transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(5): 646-650. DOI: 10.3969/j.issn.1674-7445.2020.05.019

Research progress on risk factors of de novo malignancy after liver transplantation

  • De novo malignancy after liver transplantation is an important factor that affecting the long-term survival of recipient. The main risk factors for de novo malignancy include immunosuppression and many factors of recipients, such as age, gender, race, primary disease, preoperative tumor history and precancerous lesion, carcinogenic virus infection, smoking and drinking, etc. Currently, there is no standardized monitoring scheme after liver transplantation, but planned monitoring is required for high-risk recipients, thus to achieve early diagnosis and improve the survival rate. This article summarized the incidence, prognosis and related risk factors of de novo malignancy after liver transplantation, which provided reference for improving long-term survival rate of recipients after liver transplantation.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return